178 related articles for article (PubMed ID: 21060200)
1. Prevalence of hepatitis C virus infection among hemodialysis patients in a single center in Yemen.
Selm SB
Saudi J Kidney Dis Transpl; 2010 Nov; 21(6):1165-8. PubMed ID: 21060200
[TBL] [Abstract][Full Text] [Related]
2. Low prevalence of anti-hepatitis C virus antibodies in female hemodialysis patients without blood transfusion: a multicenter analysis.
Nakayama E; Liu JH; Akiba T; Marumo F; Sato C
J Med Virol; 1996 Mar; 48(3):284-8. PubMed ID: 8801291
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of hepatitis C virus antibody in patients on chronic hemodialysis.
Nomiyama K; Tsuji H; Ikeda K; Kawatoko T; Kashiwagi S; Nakamura S; Fujishima M
Fukuoka Igaku Zasshi; 1998 Aug; 89(8):232-7. PubMed ID: 9778915
[TBL] [Abstract][Full Text] [Related]
4. [Infection of hepatitis C virus in patients with chronic renal failure undergoing hemodialysis therapy and staff members].
Miyasaka M
Nihon Jinzo Gakkai Shi; 1991 Oct; 33(10):989-99. PubMed ID: 1722830
[TBL] [Abstract][Full Text] [Related]
5. Incidence of hepatitis C infection in patients on hemodialysis: a multicenter study of northern part of Iran.
Zamani F; Ameli M; Razmjou S; Shakeri R; Amiri A; Darvish R
Saudi J Kidney Dis Transpl; 2010 Nov; 21(6):1169-71. PubMed ID: 21060201
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H
Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434
[TBL] [Abstract][Full Text] [Related]
7. [Prevalence and incidence of hepatitis C seroconversion in patients on hemodialysis].
Resić H; Sahović V; Mesić E; Leto E
Acta Med Croatica; 2003; 57(1):39-42. PubMed ID: 12876861
[TBL] [Abstract][Full Text] [Related]
8. Anti-ENA antibody profile in hepatitis C patients undergoing hemodialysis.
Batchoun RG; Al-Najdawi MA; Al-Taamary S
Saudi J Kidney Dis Transpl; 2011 Jul; 22(4):682-8. PubMed ID: 21743211
[TBL] [Abstract][Full Text] [Related]
9. Extrahepatic immunological manifestations of hepatitis C virus in dialysis patients.
Canavese C; Hollò Z; Ciccone G; Ghisetti V; Barbui A; Fop F; Martina G; Forgnone F; Novo P; Thea A; Grill A; Marchiaro G
J Nephrol; 2000; 13(5):352-9. PubMed ID: 11063139
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of anti-HCV in patients on long-term hemodialysis.
Oguchi H; Terashima M; Tokunaga S; Kiyosawa K; Tanaka E; Furuta S; Kanno Y; Aizawa T; Nishioka K
Nihon Jinzo Gakkai Shi; 1990 Mar; 32(3):313-7. PubMed ID: 2113144
[TBL] [Abstract][Full Text] [Related]
11. The impact of nurse understaffing on the transmission of hepatitis C virus in a hospital-based hemodialysis unit.
Saxena AK; Panhotra BR
Med Princ Pract; 2004; 13(3):129-35. PubMed ID: 15073424
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C viral infection in a Chinese hemodialysis unit.
Li H; Wang SX
Chin Med J (Engl); 2010 Dec; 123(24):3574-7. PubMed ID: 22166633
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C infection in dialysis patients in Israel.
Weinstein T; Tur-Kaspa R; Chagnac A; Korzets A; Ori Y; Zevin D; Herman M; Gafter U
Isr Med Assoc J; 2001 Mar; 3(3):174-7. PubMed ID: 11303373
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of hepatitis C virus antibodies in hemodialysis patients and dialysis staff.
Fujiyama S; Kawano S; Sato S; Tanaka M; Goto M; Taura Y; Sato T; Kawahara T; Mizuno K
Hepatogastroenterology; 1992 Apr; 39(2):161-5. PubMed ID: 1378811
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of hepatitis C in patients with type 2 diabetes mellitus and non-diabetic on haemodialysis.
Ocak S; Duran N; Kaya H; Emir I
Int J Clin Pract; 2006 Jun; 60(6):670-4. PubMed ID: 16805751
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and epidemiology of hepatitis C infection in patients on peritoneal dialysis in France. French PD centers.
Durand PY; Chanliau J; Gamberoni J; Hestin D; Kessler M
Adv Perit Dial; 1996; 12():167-70. PubMed ID: 8865894
[TBL] [Abstract][Full Text] [Related]
17. Changes in prevalence of anti-HCV antibodies associated with preventive measures among hemodialysis patients and dialysis staff.
Fujiyama S; Kawano S; Sato S; Shimada H; Matsushita K; Ikezaki N; Nakano T; Sato T
Hepatogastroenterology; 1995 Apr; 42(2):162-5. PubMed ID: 7545641
[TBL] [Abstract][Full Text] [Related]
18. [Anti HCV in hemodialyzed patients: reduction of the prevalence and association with epidemiological variables].
Padrone M; Corallini O; Cocozzella D; Malca M; Borzi S; Barrio M; Adrover RE; Cuffini AM; Gomez C; Giamona AM; Brawlasky G; Newmann P; Dell Amo M; Fraquelli E; Curciarello JO
Acta Gastroenterol Latinoam; 1999; 29(3):91-4. PubMed ID: 10533653
[TBL] [Abstract][Full Text] [Related]
19. Factors associated to the prevalence of antibodies to hepatitis C virus among patients receiving hemodialysis at selected dialysis centers in Puerto Rico, 2005.
Soto-Salgado M; Pérez CM; Burgos-Calderón R; Torres EA; Suárez E
P R Health Sci J; 2009 Mar; 28(1):18-23. PubMed ID: 19266735
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis virus infection (HBV and HCV) in eleven Japanese hemodialysis units.
Oguchi H; Miyasaka M; Tokunaga S; Hora K; Ichikawa S; Ochi T; Yamada K; Nagasawa M; Kanno Y; Aizawa T
Clin Nephrol; 1992 Jul; 38(1):36-43. PubMed ID: 1499167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
